Catherine Gagnon
Nessuna posizione attualmente
Storia della carriera di Catherine Gagnon
Precedenti posizioni note di Catherine Gagnon
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Katana Biopharma, Inc.
 Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Katana Biopharma, Inc. operates oncology related technology platform. It develops a proprietary technology platform using peptides as a vehicle to specifically deliver existing cytotoxic agents to sortilin receptors, which are overexpressed on cancer cells. The company was founded by Richard Béliveau and Borhane Annabi in 2016 is headquartered in Montréal, Canada. | Direttore/Membro del Consiglio | - | - |
Ovensa, Inc.
 Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Direttore/Membro del Consiglio | - | - |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
Formazione di Catherine Gagnon
| University of Montréal | Graduate Degree |
Statistiche
Distribuzione geografica
| Canada | 5 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Technology Services |
Katana Biopharma, Inc.
Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Katana Biopharma, Inc. operates oncology related technology platform. It develops a proprietary technology platform using peptides as a vehicle to specifically deliver existing cytotoxic agents to sortilin receptors, which are overexpressed on cancer cells. The company was founded by Richard Béliveau and Borhane Annabi in 2016 is headquartered in Montréal, Canada. | Health Services |
- Borsa valori
- Insiders
- Catherine Gagnon
- Esperienza
